Screener
Regenxbio RGNX Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other Comprehensive Income (Loss) | ||||
| Unrealized gain (loss) on available-for-sale securities, net | (5) | 12 | (188) | (9) |
| Total other comprehensive income (loss) | (5) | 12 | (188) | (9) |
| Comprehensive income (loss) | $22,704 | $(70,859) | $(67,530) | $(64,797) |
| Net income (loss) per share: | ||||
| Basic | $0.43 | $(1.38) | $(1.28) | $(1.26) |
| Diluted | $0.43 | $(1.38) | $(1.28) | $(1.26) |
| Weighted-average common shares outstanding: |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's comprehensive income (loss), net of tax, attributable to parent?
- Regenxbio (RGNX) reported comprehensive income (loss), net of tax, attributable to parent of $22.7M in Q2 2026.
- How has Regenxbio's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Regenxbio's comprehensive income (loss), net of tax, attributable to parent increased by 132.0% year-over-year, from -$70.86M to $22.7M.
- What is the long-term trend for Regenxbio's comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Regenxbio's comprehensive income (loss), net of tax, attributable to parent has grown at a 11.4% compound annual growth rate (CAGR), from $125.63M to -$193.82M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This is the final measure of a company's total financial performance, combining net income with other comprehensive income items. It represents the total change in equity from non-owner sources during the reporting period. Investors use this to evaluate the comprehensive impact of all financial activities, including market-driven fluctuations, on the company's net worth.
Ask your AI about Regenxbio's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude